New Insulins, Biosimilars, and Insulin Therapy
Diabetes Technol Ther
.
2024 Mar;26(S1):S45-S67.
doi: 10.1089/dia.2024.2504.
Authors
Thomas Danne
1
,
Lutz Heinemann
2
,
Thomas R Pieber
3
Affiliations
1
Diabetes-Zentrum für Kinder and Jugendliche, Kinder- und Jugendkrankenhaus "AUF DER BULT," Hannover, Germany.
2
Science Consulting in Diabetes GmbH, Düsseldorf, Germany.
3
Department of Internal Medicine, Division of Endocrinology and Diabetology, Medical University of Graz, Graz, Austria.
PMID:
38441455
DOI:
10.1089/dia.2024.2504
No abstract available
MeSH terms
Biosimilar Pharmaceuticals* / therapeutic use
Humans
Insulin / therapeutic use
Insulin, Regular, Human
Insulins* / therapeutic use
Substances
Insulin
Biosimilar Pharmaceuticals
Insulin, Regular, Human
Insulins